Lv4
416 积分 2025-01-17 加入
Pharmacovigilance assessment of ropivacaine safety using FAERS data (2004–2024)
5天前
已完结
The real-world safety profile and potential mechanism of isatuximab: Integration of pharmacovigilance and transcriptomic analysis
5天前
已完结
Novel insights into post-marketing AEs associated with bempedoic acid: A comprehensive analysis utilizing the FAERS database
5天前
已完结
Comprehensive analysis of metformin-associated lactic acidosis: Insights from the FDA Adverse Event Reporting System (FAERS)
20天前
已完结
Disproportionality analysis of adverse events associated with bimekizumab: a real-world study based on FDA Adverse Event Reporting System (FAERS) Database
20天前
已完结
Evaluating adverse events of antibacterials in infants: insights from FDA adverse event reporting system (FAERS) data
20天前
已完结
Adverse events associated with ustekinumab in Crohn's disease treatment: an analysis based on the FAERS database
29天前
已完结
Assessing the real-world safety of fenofibric acid for hyperlipidemia: results from WHO-VigiAccess and FAERS databases
29天前
已完结
Safety assessment of basiliximab using real-world adverse event data from the FDA Adverse Event Reporting System Database: A retrospective observational study
1个月前
已完结
Adverse events associated with third-generation cephalosporins: Analysis of the FDA adverse event reporting system database
1个月前
已完结
皖公网安备34019202002308
